A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Clinical trial NCT02399813 · COMPLETED

Trial details

NCT number: NCT02399813
Sponsor: Advaxis, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Cancer Rectal Cancer

Start date: 2016-06-02
Primary completion: 2019-01-03
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.